These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Epstein-Barr virus infection and the expression of bcl-2 proto-oncogene in Hodgkin's disease]. Liu C, Liao S, Gao Z. Zhonghua Bing Li Xue Za Zhi; 1997 Jun; 26(3):155-7. PubMed ID: 10072857 [Abstract] [Full Text] [Related]
3. Epstein-Barr virus-latent gene expression and tumor cell phenotype in acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma. Correlation of lymphoma phenotype with three distinct patterns of viral latency. Hamilton-Dutoit SJ, Rea D, Raphael M, Sandvej K, Delecluse HJ, Gisselbrecht C, Marelle L, van Krieken HJ, Pallesen G. Am J Pathol; 1993 Oct; 143(4):1072-85. PubMed ID: 8214003 [Abstract] [Full Text] [Related]
4. High expression of latent membrane protein 1 of Epstein-Barr virus and BCL-2 oncoprotein in acquired immunodeficiency syndrome-related primary brain lymphomas. Camilleri-Broët S, Davi F, Feuillard J, Bourgeois C, Seilhean D, Hauw JJ, Raphaël M. Blood; 1995 Jul 15; 86(2):432-5. PubMed ID: 7605982 [Abstract] [Full Text] [Related]
6. BCL-6 protein expression in AIDS-related non-Hodgkin's lymphomas: inverse relationship with Epstein-Barr virus-encoded latent membrane protein-1 expression. Carbone A, Gaidano G, Gloghini A, Pastore C, Saglio G, Tirelli U, Dalla-Favera R, Falini B. Am J Pathol; 1997 Jan 01; 150(1):155-65. PubMed ID: 9006332 [Abstract] [Full Text] [Related]
7. Latent membrane protein of Epstein-Barr virus induces cellular phenotypes independently of expression of Bcl-2. Martin JM, Veis D, Korsmeyer SJ, Sugden B. J Virol; 1993 Sep 01; 67(9):5269-78. PubMed ID: 8394449 [Abstract] [Full Text] [Related]
8. Expression of bcl-2 protein and Epstein-Barr virus latent membrane protein in Hodgkin's disease. Kordek R, Biernat W, Kupnicka D, Woźniak L. Pol J Pathol; 1994 Sep 01; 45(4):279-81. PubMed ID: 7697330 [Abstract] [Full Text] [Related]
9. Lack of correlation between expression of Epstein-Barr virus (EBV) latent membrane protein and bcl-2 oncoprotein in vivo. Tao Q, Srivastava G, Loke SL, Ho FC. J Clin Pathol; 1994 Jul 01; 47(7):589-91. PubMed ID: 8089211 [Abstract] [Full Text] [Related]
10. Epstein-Barr virus infection is an early event in gastric carcinogenesis and is independent of bcl-2 expression and p53 accumulation. Gulley ML, Pulitzer DR, Eagan PA, Schneider BG. Hum Pathol; 1996 Jan 01; 27(1):20-7. PubMed ID: 8543306 [Abstract] [Full Text] [Related]
11. Morphologic differences between latent membrane protein-1 (LMP-1)-positive and negative tumour cells in Epstein-Barr virus (EBV)-related childhood Hodgkin's disease. A morphometric study. Panayiotides J, Kanavaros P, Protopapa E, Vlachonikolis J, Tzardi M, Kalmanti M, Delides G. Pathol Res Pract; 1996 Mar 01; 192(3):210-4. PubMed ID: 8739467 [Abstract] [Full Text] [Related]
12. Epstein-Barr virus strains with latent membrane protein-1 deletions: prevalence in the Italian population and high association with human immunodeficiency virus-related Hodgkin's disease. Dolcetti R, Zancai P, De Re V, Gloghini A, Bigoni B, Pivetta B, De Vita S, Carbone A, Boiocchi M. Blood; 1997 Mar 01; 89(5):1723-31. PubMed ID: 9057656 [Abstract] [Full Text] [Related]
13. The prognostic relevance of apoptosis-related proteins in classical Hodgkin's lymphomas. Vassallo J, Metze K, Traina F, de Souza CA, Lorand-Metze I. Leuk Lymphoma; 2003 Mar 01; 44(3):483-8. PubMed ID: 12688319 [Abstract] [Full Text] [Related]
14. The molecular and phenotypic profile of primary central nervous system lymphoma identifies distinct categories of the disease and is consistent with histogenetic derivation from germinal center-related B cells. Larocca LM, Capello D, Rinelli A, Nori S, Antinori A, Gloghini A, Cingolani A, Migliazza A, Saglio G, Cammilleri-Broet S, Raphael M, Carbone A, Gaidano G. Blood; 1998 Aug 01; 92(3):1011-9. PubMed ID: 9680371 [Abstract] [Full Text] [Related]
15. Expression of the simian Epstein-Barr virus-encoded latent membrane protein-1 in malignant lymphomas of SIV-infected rhesus macaques. Blaschke S, Hannig H, Buske C, Kaup FJ, Hunsmann G, Bodemer W. J Med Virol; 2001 Sep 01; 65(1):114-20. PubMed ID: 11505452 [Abstract] [Full Text] [Related]
16. Oncogene expression in tumour cells of pediatric Hodgkin's disease in Argentina--correlation with Epstein Barr virus presence. Preciado MV, Cristobal E, Menarguez J, Martinez Montero JC, Diez B, De Matteo E, Grinstein S. Pathol Res Pract; 1998 Sep 01; 194(1):25-31. PubMed ID: 9542744 [Abstract] [Full Text] [Related]
17. Expression of Bcl-2 family members and presence of Epstein-Barr virus in the regulation of cell growth and death in classical Hodgkin's lymphoma. Kim LH, Nadarajah VS, Peh SC, Poppema S. Histopathology; 2004 Mar 01; 44(3):257-67. PubMed ID: 14987230 [Abstract] [Full Text] [Related]
18. Epstein-Barr virus-associated nonsmall cell lung carcinoma: undifferentiated "lymphoepithelioma-like" carcinoma as a distinct entity with better prognosis. Chen FF, Yan JJ, Lai WW, Jin YT, Su IJ. Cancer; 1998 Jun 15; 82(12):2334-42. PubMed ID: 9635525 [Abstract] [Full Text] [Related]
19. Expression of c-myc and bcl-2 oncogene products in Reed-Sternberg cells independent of presence of Epstein-Barr virus. Jiwa NM, Kanavaros P, van der Valk P, Walboomers JM, Horstman A, Vos W, Mullink H, Meijer CJ. J Clin Pathol; 1993 Mar 15; 46(3):211-7. PubMed ID: 8385158 [Abstract] [Full Text] [Related]
20. Expression of Epstein-Barr virus latent gene products and related cellular activation and adhesion molecules in Hodgkin's disease and non-Hodgkin's lymphomas arising in patients without overt pre-existing immunodeficiency. Kanavaros P, Jiwa M, van der Valk P, Walboomers J, Horstman A, Meijer CJ. Hum Pathol; 1993 Jul 15; 24(7):725-9. PubMed ID: 8100553 [Abstract] [Full Text] [Related] Page: [Next] [New Search]